Suppr超能文献

玻璃体腔内注射用聚维酮碘制剂后眼冲洗量对表面刺激的影响:一项随机对照试验

The effect of ocular rinse volume on surface irritation after povidone-iodine preparation for intravitreal injections: a randomized controlled trial.

作者信息

Jamshidi Farzad, Jin Haoxing D, Bruce Andrew, Kutteh Michael, Ding Kai, Riaz Kamran M, Kingsley Ronald M, Shah Vinay A

机构信息

Department of Ophthalmology, Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, 608 Stanton L Young Blvd, Oklahoma City, OK, 73104, USA.

Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA, USA.

出版信息

Int J Retina Vitreous. 2023 Sep 28;9(1):59. doi: 10.1186/s40942-023-00470-z.

Abstract

PURPOSE

To evaluate whether the volume of wash out rinse after povidone iodine (PI) application for intravitreal injections (IVI) affects patients' ocular surface irritation.

METHODS

This was a prospective, single-masked, randomized-controlled trial consisting of 142 subjects. A total of 51, 45, and 46 patients received 3-mL, 10-mL, and 15-mL of ocular rinse respectively. Reductions in the Ocular Surface Disease Index (OSDI) and the Standardized Patient Evaluation of Eye Dryness II (SPEED II) surveys, conducted before and at 24-72 h post-injection, were analyzed.

RESULTS

There was no statistical difference in objective dry eye findings of Schirmer test (p-value = 0.788), tear break-up time (p-value = 0.403), Oxford fluorescein grade (p-value = 0.424) between the study groups prior to injections. Dry eye symptoms as measured by reductions in the OSDI and SPEEDII scores were not different between the study groups (p-value = 0.0690 and 0.6227, respectively).

CONCLUSION

There is no difference in patients' ocular surface irritation between 3-mL, 10-mL, and 15-mL post injection rinse. Given the large number of IVIs performed, modification of practice patterns based on these findings could lead to significant reduction in global cost burden for IVIs.

摘要

目的

评估玻璃体内注射(IVI)时应用聚维酮碘(PI)后冲洗液的体积是否会影响患者的眼表刺激。

方法

这是一项前瞻性、单盲、随机对照试验,共纳入142名受试者。分别有51、45和46名患者接受了3毫升、10毫升和15毫升的眼部冲洗。分析注射前及注射后24 - 72小时进行的眼表疾病指数(OSDI)和干眼标准化患者评估II(SPEED II)调查的降低情况。

结果

注射前各研究组间泪液分泌试验(Schirmer试验)的客观干眼结果(p值 = 0.788)、泪膜破裂时间(p值 = 0.403)、牛津荧光素分级(p值 = 0.424)无统计学差异。各研究组间通过OSDI和SPEEDII评分降低来衡量的干眼症状无差异(p值分别为0.0690和0.6227)。

结论

注射后3毫升、10毫升和15毫升冲洗液在患者眼表刺激方面无差异。鉴于进行的玻璃体内注射数量众多,基于这些发现改变操作模式可能会显著降低玻璃体内注射的全球成本负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a3/10537205/e5020aaa7b93/40942_2023_470_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验